Differentially expressed circulating microRNAs in the development of acute diabetic Charcot foot

Jennifer Pasquier, Vimal Ramachandran, Moh'D Rasheed Abu-Qaoud, Binitha Thomas, Manasi J. Benurwar, Omar Chidiac, Jessica Hoarau, Amal Robay, Khalid Adnan Mohamed A. Fakhro, Robert A. Menzies, Amin Jayyousi, Mahmoud Zirie, Jassim Al Suwaidi, Rayaz Malik, Talal K. Talal, Hani Najafi, Arash Rafii Tabrizi, Charbel Abi Khalil

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Aim: Charcot foot (CF) is a rare complication of Type 2 diabetes (T2D). Materials & methods: We assessed circulating miRNAs in 17 patients with T2D and acute CF (G1), 17 patients with T2D (G2) and equivalent neuropathy and 17 patients with T2D without neuropathy (G3) using the high-throughput miRNA expression profiling. Results: 51 significantly deregulated miRNAs were identified in G1 versus G2, 37 in G1 versus G3 and 64 in G2 versus G3. Furthermore, we demonstrated that 16 miRNAs differentially expressed between G1 versus G2 could be involved in osteoclastic differentiation. Among them, eight are key factors involved in CF pathophysiology. Conclusion: Our data reveal that CF patients exhibit an altered expression profile of circulating miRNA.

Original languageEnglish
Pages (from-to)1267-1278
Number of pages12
JournalEpigenomics
Volume10
Issue number10
DOIs
Publication statusPublished - 1 Oct 2018

Fingerprint

Diabetic Foot
MicroRNAs
Type 2 Diabetes Mellitus
Foot

Keywords

  • Charcot foot
  • diabetes
  • epigenetics
  • inflammation
  • micro-RNA

ASJC Scopus subject areas

  • Genetics
  • Cancer Research

Cite this

Differentially expressed circulating microRNAs in the development of acute diabetic Charcot foot. / Pasquier, Jennifer; Ramachandran, Vimal; Abu-Qaoud, Moh'D Rasheed; Thomas, Binitha; Benurwar, Manasi J.; Chidiac, Omar; Hoarau, Jessica; Robay, Amal; Fakhro, Khalid Adnan Mohamed A.; Menzies, Robert A.; Jayyousi, Amin; Zirie, Mahmoud; Al Suwaidi, Jassim; Malik, Rayaz; Talal, Talal K.; Najafi, Hani; Tabrizi, Arash Rafii; Abi Khalil, Charbel.

In: Epigenomics, Vol. 10, No. 10, 01.10.2018, p. 1267-1278.

Research output: Contribution to journalArticle

@article{694b3d50b15246218b6a3b4f5421a21b,
title = "Differentially expressed circulating microRNAs in the development of acute diabetic Charcot foot",
abstract = "Aim: Charcot foot (CF) is a rare complication of Type 2 diabetes (T2D). Materials & methods: We assessed circulating miRNAs in 17 patients with T2D and acute CF (G1), 17 patients with T2D (G2) and equivalent neuropathy and 17 patients with T2D without neuropathy (G3) using the high-throughput miRNA expression profiling. Results: 51 significantly deregulated miRNAs were identified in G1 versus G2, 37 in G1 versus G3 and 64 in G2 versus G3. Furthermore, we demonstrated that 16 miRNAs differentially expressed between G1 versus G2 could be involved in osteoclastic differentiation. Among them, eight are key factors involved in CF pathophysiology. Conclusion: Our data reveal that CF patients exhibit an altered expression profile of circulating miRNA.",
keywords = "Charcot foot, diabetes, epigenetics, inflammation, micro-RNA",
author = "Jennifer Pasquier and Vimal Ramachandran and Abu-Qaoud, {Moh'D Rasheed} and Binitha Thomas and Benurwar, {Manasi J.} and Omar Chidiac and Jessica Hoarau and Amal Robay and Fakhro, {Khalid Adnan Mohamed A.} and Menzies, {Robert A.} and Amin Jayyousi and Mahmoud Zirie and {Al Suwaidi}, Jassim and Rayaz Malik and Talal, {Talal K.} and Hani Najafi and Tabrizi, {Arash Rafii} and {Abi Khalil}, Charbel",
year = "2018",
month = "10",
day = "1",
doi = "10.2217/epi-2018-0052",
language = "English",
volume = "10",
pages = "1267--1278",
journal = "Epigenomics",
issn = "1750-1911",
publisher = "Future Medicine Ltd.",
number = "10",

}

TY - JOUR

T1 - Differentially expressed circulating microRNAs in the development of acute diabetic Charcot foot

AU - Pasquier, Jennifer

AU - Ramachandran, Vimal

AU - Abu-Qaoud, Moh'D Rasheed

AU - Thomas, Binitha

AU - Benurwar, Manasi J.

AU - Chidiac, Omar

AU - Hoarau, Jessica

AU - Robay, Amal

AU - Fakhro, Khalid Adnan Mohamed A.

AU - Menzies, Robert A.

AU - Jayyousi, Amin

AU - Zirie, Mahmoud

AU - Al Suwaidi, Jassim

AU - Malik, Rayaz

AU - Talal, Talal K.

AU - Najafi, Hani

AU - Tabrizi, Arash Rafii

AU - Abi Khalil, Charbel

PY - 2018/10/1

Y1 - 2018/10/1

N2 - Aim: Charcot foot (CF) is a rare complication of Type 2 diabetes (T2D). Materials & methods: We assessed circulating miRNAs in 17 patients with T2D and acute CF (G1), 17 patients with T2D (G2) and equivalent neuropathy and 17 patients with T2D without neuropathy (G3) using the high-throughput miRNA expression profiling. Results: 51 significantly deregulated miRNAs were identified in G1 versus G2, 37 in G1 versus G3 and 64 in G2 versus G3. Furthermore, we demonstrated that 16 miRNAs differentially expressed between G1 versus G2 could be involved in osteoclastic differentiation. Among them, eight are key factors involved in CF pathophysiology. Conclusion: Our data reveal that CF patients exhibit an altered expression profile of circulating miRNA.

AB - Aim: Charcot foot (CF) is a rare complication of Type 2 diabetes (T2D). Materials & methods: We assessed circulating miRNAs in 17 patients with T2D and acute CF (G1), 17 patients with T2D (G2) and equivalent neuropathy and 17 patients with T2D without neuropathy (G3) using the high-throughput miRNA expression profiling. Results: 51 significantly deregulated miRNAs were identified in G1 versus G2, 37 in G1 versus G3 and 64 in G2 versus G3. Furthermore, we demonstrated that 16 miRNAs differentially expressed between G1 versus G2 could be involved in osteoclastic differentiation. Among them, eight are key factors involved in CF pathophysiology. Conclusion: Our data reveal that CF patients exhibit an altered expression profile of circulating miRNA.

KW - Charcot foot

KW - diabetes

KW - epigenetics

KW - inflammation

KW - micro-RNA

UR - http://www.scopus.com/inward/record.url?scp=85054759724&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054759724&partnerID=8YFLogxK

U2 - 10.2217/epi-2018-0052

DO - 10.2217/epi-2018-0052

M3 - Article

C2 - 29869523

AN - SCOPUS:85054759724

VL - 10

SP - 1267

EP - 1278

JO - Epigenomics

JF - Epigenomics

SN - 1750-1911

IS - 10

ER -